A behavioural model to reveal place preference to Δ9- tetrahydrocannabinol in mice

Psychopharmacology

Volumn 147, Issue 4, 2000, Pages 436-438

  Valjent, Emmanuel ^a,b   Maldonado, Rafael ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b CNRS   (France)

Author keywords

Mouse; Place preference; Reward; SR 141716A; 9 Tetrahydrocannabinol

Indexed keywords

CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; RIMONABANT;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSION; CANNABIS ADDICTION; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; DYSPHORIA; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD;

EID: 0033972058     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050013     Document Type: Article

References (21)

1. Adams IB, Martin BR (1996) Cannabis: pharmacology and toxicology in animals and humans. Addiction 91:1585-1614
2. D'Ambra TE, Espep KG, Bell MR, Eissenstat MA, Josef KA, Ward SJ, Haycock DA, Baizman ER, Casiano FM, Beglin NC, Chippari SM, Grego JD, Kullnig RK, Daley GT (1992) Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl) indole agonists of the cannabinoid receptor. J Med Chem 35:124-135
3. Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613
4. Di Chiara G, Acquas E, Carboni E (1991) Role of the mesolimbic dopamine in the motivational effects of drugs: brain dialysis and place preference studies. In: Willner P, Scheel-Kruger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, London, pp 331-366
5. Eldridge JC, Landfield PW (1992) Cannabinoid-glucocorticoid interactions in the hippocampal region of the brain. In: Murphy L, Bartke A (eds) Marijuana/cannabinoids: neurobiology and neurophysiology. CRC Press, Boca Raton, Fla., pp 93-117
6. French ED, Dillon K, Wu X (1997) Cannabinoids excite dopamine neurons in the ventral tegmentum and substancia nigra. NeuroReport 8:649-652
7. Gessa GL, Melis M, Muntoni AL, Diana M (1998) Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341:39-44
8. Hutcheson DM, Tzavara ET, Smadja C, Valjent E, Roques BP, Hanoune J, Maldonado R (1998) Behavioral and biochemical evidence for signs of abstinence in mice chronically treated with Δ9-tetrahydrocannabinol. Br J Pharmacol 125:1567-1577
9. Leite JR, Carlini EA (1974) Failure to obtain 'cannabis-directed behavior' and abstinence syndrome in rats chronically treated with cannabis saliva extracts. Psychopharmacologia 36:133-145
10. Lepore M, Vorel S, Lowinson JH, Gardner EL (1995) Conditionned place preference induced by Δ9-tetrahydrocannabinol comparison with cocaine, morphine, and food reward. Life Sci 56:2073-2080
11. 2 receptors. Nature 388:586-589
12. Mallet PE, Beninger RJ (1998) Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. Life Sci 62:2431-2439
13. Martellota MC, Cossu G, Gessa GL, Fratta W (1998) Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience 85:327-330
14. McGregor IS, Issakidis CN, and Prior G (1996) Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacol Biochem Behav 53:657-664
15. Onaivi ES, Green MR, Martin BR (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253:1002-1009
16. Parker LA, Gillies T (1995) THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behav Neurosci 109: 71-78
17. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G (1994) SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244
18. Rodriguez De Fonseca F, Carrera MRA, Navarro M, Koob GF, Weiss F (1997) Activation of corticotropin-releasing factor in the linmbic system during cannabinoid withdrawal. Science 276: 2050-2054
19. Sanudo-Pena MC, Tsou K, Delay ER, Hohman AG, Force M, Walker JM (1997) Endogenous Cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett 223:125-128
20. 1-opiod receptor mechanism. Science 276:2048-2050
21. Van Ree JM, Slangen J, De Wied D (1978) Intravenous self-administration of drugs in rats. J Pharmacol Exp Ther 20: 547-557